WAYRILZ Trademark

Trademark Overview


On Monday, October 7, 2024, a trademark application was filed for WAYRILZ with the United States Patent and Trademark Office. The USPTO has given the WAYRILZ trademark a serial number of 98787964. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Monday, April 13, 2026. This trademark is owned by Principia Biopharma Inc.. The WAYRILZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of inflammatory, autoimmune, immune-mediated, immune-system related, and rare immune, autoimmune, immune-mediated, immune-system related, inflammatory, blood, and hematological diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the blood
wayrilz

General Information


Serial Number98787964
Word MarkWAYRILZ
Filing DateMonday, October 7, 2024
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateMonday, April 13, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of inflammatory, autoimmune, immune-mediated, immune-system related, and rare immune, autoimmune, immune-mediated, immune-system related, inflammatory, blood, and hematological diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the blood

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 7, 2024
Primary Code005
First Use Anywhere DateTuesday, September 30, 2025
First Use In Commerce DateTuesday, September 30, 2025

Trademark Owner History


Party NamePrincipia Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
US

Party NamePrincipia Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807
US

Trademark Events


Event DateEvent Description
Monday, October 7, 2024NEW APPLICATION ENTERED
Monday, October 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 18, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, December 4, 2024ASSIGNED TO LIE
Wednesday, December 4, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, March 20, 2025ASSIGNED TO EXAMINER
Sunday, March 30, 2025NON-FINAL ACTION WRITTEN
Sunday, March 30, 2025NON-FINAL ACTION E-MAILED
Sunday, March 30, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 29, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 29, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 29, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 28, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 3, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 3, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, June 26, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 26, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 26, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 26, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, October 7, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 3, 2025TEAS STATEMENT OF USE RECEIVED
Monday, April 13, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 3, 2025USE AMENDMENT FILED
Monday, April 13, 2026STATEMENT OF USE PROCESSING COMPLETE